Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 6/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | MTOR | P42345 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nonane SCHEMBL11639112 | 1.00 | USP2 (0.60) | USP2LMNAALDH1A1MEN1KMT2A | |
| Decane SCHEMBL27510417 | 1.00 | USP2 (0.60) | USP2LMNAALDH1A1MEN1KMT2A | |
| Dodecane SCHEMBL16652552 | 1.00 | USP2 (0.60) | USP2LMNAALDH1A1MEN1KMT2A | |
| Hexadecane SCHEMBL4476638 | 1.00 | USP2 (0.60) | USP2LMNAALDH1A1MEN1KMT2A | |
| Octane SCHEMBL2362539 | 1.00 | USP2 (0.60) | USP2LMNAALDH1A1MEN1KMT2A | |
| Heptane SCHEMBL8025180 | 1.00 | USP2 (0.60) | USP2LMNAALDH1A1MEN1KMT2A | |
| Octane SCHEMBL3691269 | 1.00 | USP2 (0.60) | USP2LMNAALDH1A1MEN1KMT2A | |
| Glycerin SCHEMBL28505432 | 1.00 | USP2 (0.60) | USP2LMNAALDH1A1MEN1KMT2A | |
| Octane SCHEMBL2522455 | 1.00 | USP2 (0.60) | USP2LMNAALDH1A1MEN1KMT2A | |
| Tetradecane SCHEMBL27410093 | 1.00 | USP2 (0.60) | USP2LMNAALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113905796-A | Novel solvents for extracting, dissolving and/or formulating volatile and non-volatile compounds of interest in nutrition and animal health, method for the production and use thereof | 艾迪福科技有限公司 | 2022-01-07 | — | — | CN | disclosed |
| CN-109496148-B | Skin whitening cosmetic composition containing glyceryl laurate | 明进新科技股份公司 | 2021-09-17 | — | — | CN | disclosed |
| US-9244372-B2 | Electrostatic charge image developing toner, electrostatic charge image developer, and toner cartridge | FUJI XEROX CO., LTD. (JP) | 2016-01-26 | — | — | US | disclosed |
| US-20150111139-A1 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, AND TONER CARTRIDGE | FUJI XEROX CO., LTD. (JP) | 2015-04-23 | — | — | US | disclosed |
| EP-1786381-B1 | ANTI-BACTERIAL COMPOUNDS | BEIERSDORF AG (DE) | 2014-12-03 | — | — | EP | disclosed |
| CN-101018538-B | Antibacterial compounds | GIVAUDAN SA | 2011-05-04 | — | — | CN | disclosed |
| US-20090022764-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2009-01-22 | — | — | US | disclosed |
| US-7459581-B2 | Anti-bacterial compounds | GIVAUDAN S.A. (CH) | 2008-12-02 | — | — | US | disclosed |
| US-20080070985-A1 | Anti-Bacterial Compounds | BEIERSDORF AG (DE) | 2008-03-20 | — | — | US | disclosed |
| US-20070276045-A1 | Anti-Bacterial Compounds | GIVAUDAN S.A. (CH) | 2007-11-29 | — | — | US | disclosed |
| CN-101018538-A | Antibacterial compounds | GIVAUDAN SA (CH) | 2007-08-15 | — | — | CN | disclosed |
| EP-1788871-A1 | ROMP POLYMER PARTICLES COMPRISING ACTIVE INGREDIENTS | Givaudan SA (CH) | 2007-05-30 | — | — | EP | disclosed |
| EP-1786756-A1 | ANTI-BACTERIAL COMPOUNDS | Givaudan SA (CH) | 2007-05-23 | — | — | EP | disclosed |
| EP-1786381-A1 | ANTI-BACTERIAL COMPOUNDS | Givaudan SA (CH) | 2007-05-23 | — | — | EP | disclosed |
| WO-2006026875-A1 | ANTI-BACTERIAL COMPOUNDS | GIVAUDAN SA (CH) | 2006-03-16 | — | — | WO | disclosed |
| WO-2006026876-A1 | ANTI-BACTERIAL COMPOUNDS | GIVAUDAN SA (CH) | 2006-03-16 | — | — | WO | disclosed |
| WO-2006024184-A1 | ROMP POLYMER PARTICLES COMPRISING ACTIVE INGREDIENTS | GIVAUDAN SA (CH) | 2006-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080070985-A1 | Anti-Bacterial Compounds | H1-0, H1-3, LBR | USP2 4223/4885LMNA 214/4885ALDH1A1 1825/4885 |
| US-20090022764-A1 | ORGANIC COMPOUNDS | EXOSC9, EXOSC4, CYP1A1 | USP2 754/4885LMNA 4050/4885ALDH1A1 544/4885 |
| US-20070276045-A1 | Anti-Bacterial Compounds | SPOUT1, FASN, CYP8B1 | USP2 3909/4885LMNA 1116/4885ALDH1A1 1431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.